PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells

• Payel Chatterjee,

  Affiliations Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Kent State University, Kent, Ohio, United State of America

  ⨯
• Gaurav S. Choudhary,

  Affiliations Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Arishya Sharma,

  Affiliations Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Cleveland State University, Cleveland, Ohio, United States of America

  ⨯
• Kamini Singh,

  Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Warren D. Heston,

  Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Jay Ciezki,

  Affiliation Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Eric A. Klein,

  Affiliation Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Alexandru Almasan

  * E-mail: almasaa@ccf.org

  Affiliations Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯